Kari Grønås

Kari Grønås

Direktor/Vorstandsmitglied bei SPAGO NANOMEDICAL AB

Vermögen: 5 691 $ am 31.05.2024

59 Jahre
Health Technology
Commercial Services
Consumer Services

Ursprung des Netzwerks ersten Grades von Kari Grønås

EinheitArt der EinheitIndustrie
Public Company Pharmaceuticals: Major 19
Public Company Pharmaceuticals: Major 16
Public Company Biotechnology 12
8
Subsidiary Biotechnology 8
1
Private Company Miscellaneous Commercial Services 1
Norwegian Cancer Society
1
Private Company 1

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Kari Grønås

UnternehmenSektorVerknüpfte PersonenHauptposition
AMGEN INC. Pharmaceuticals: Major

Alan Barge

Antonius Berkien

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Christian Schweiger

Director/Board Member

ASTRAZENECA PLC Pharmaceuticals: Major

Alan Barge

Nicklas Westerholm

Corporate Officer/Principal

Investor Relations Contact

VERNALIS Pharmaceuticals: Major

Anthony Brown

Corporate Officer/Principal

Miscellaneous Commercial Services

Susan Foden

Anthony Brown

Director/Board Member

Corporate Officer/Principal

PCI BIOTECH HOLDING ASA Biotechnology

Kjetil Hestdal

Hilde Furberg

Chairman

Director/Board Member

Miscellaneous Commercial Services

Jónas Einarsson

Øyvind Kongstun Arnesen

Chief Executive Officer

Chairman

THERACRYF PLC Medical/Nursing Services

Susan Foden

Alan Barge

Chairman

Director/Board Member

PHOTOCURE ASA Medical Specialties

Kjetil Hestdal

Anne Hovi Worsøe

Gudrun Trøite

Chief Executive Officer

Director/Board Member

Corporate Officer/Principal

Financial Conglomerates

Jónas Einarsson

Eva Dugstad

Chief Executive Officer

Director/Board Member

University of Oxford College/University

Susan Foden

Alan Barge

Anthony Brown

Doctorate Degree

Graduate Degree

Doctorate Degree

Miscellaneous Commercial Services

Hans Arwidsson

Nicklas Westerholm

Corporate Officer/Principal

Corporate Officer/Principal

Oxford Brookes University College/University

Anthony Brown

Debbie Molyneux

Masters Business Admin

Graduate Degree

Pharmaceuticals: Generic

Christian Schweiger

Corporate Officer/Principal

Pharmaceuticals: Major

Christian Schweiger

Corporate Officer/Principal

Karolinska Institutet College/University

Eugen Steiner

Sten Nilsson

Doctorate Degree

Corporate Officer/Principal

Medical Specialties

Susan Foden

Anthony Brown

Chief Executive Officer

Corporate Officer/Principal

WEIFA ASA Pharmaceuticals: Major

Hilde Furberg

Kristin Louise A. Wilhelmsen

Director/Board Member

Director/Board Member

Financial Conglomerates

Kristin Louise A. Wilhelmsen

Haakon Stenrod

Director/Board Member

Chief Investment Officer

College/University

Audun Tornes

Tove Sivik Sonne

Graduate Degree

Doctorate Degree

University of Lund College/University

Peter Leander

Kristin Louise A. Wilhelmsen

Corporate Officer/Principal

Undergraduate Degree

University of Oslo College/University

Øyvind Eriksen

Jónas Einarsson

Hilde Furberg

Øyvind Kongstun Arnesen

Eva Dugstad

Jens Bjørheim

Gudrun Trøite

Graduate Degree

Doctorate Degree

Graduate Degree

Doctorate Degree

Undergraduate Degree

Doctorate Degree

Doctorate Degree

Financial Conglomerates

Carlos de Sousa

Antonius Berkien

Corporate Officer/Principal

Corporate Officer/Principal

Norwegian School of Economics & Business Administration College/University

Stein Holst Annexstad

Hans Vassgård Eid

Henrik Schüssler

Petter Nielsen

Undergraduate Degree

Masters Business Admin

Undergraduate Degree

Graduate Degree

Norwegian University of Science & Technology College/University

Jon-Øyvind Eriksen

Øivind Foss

Birgitte Gangmark Villmo

Haakon Stenrod

Graduate Degree

Doctorate Degree

Graduate Degree

Graduate Degree

University of Duisburg-Essen College/University

Christian Schweiger

Corporate Officer/Principal

BI Norwegian Business School College/University

Anne Hovi Worsøe

Henrik Schüssler

Graduate Degree

Undergraduate Degree

Miscellaneous Commercial Services

Henrik Schüssler

Petter Nielsen

Rune Skeie

Comptroller/Controller/Auditor

Corporate Officer/Principal

Director/Board Member

Pharmaceuticals: Major

Anthony Brown

Chief Tech/Sci/R&D Officer

Building Products

Christian Schweiger

Corporate Officer/Principal

BIOARCTIC AB Pharmaceuticals: Major

Eugen Steiner

Bengt Håkan Englund

Chairman

Director/Board Member

Investment Managers

Stein Holst Annexstad

Jon-Øyvind Eriksen

Birgitte Gangmark Villmo

Chairman

Private Equity Investor

Private Equity Analyst

Østre Aker vei 24 B AS

Henrik Schüssler

Director/Board Member

EGETIS THERAPEUTICS AB Pharmaceuticals: Major

Sten Nilsson

Nicklas Westerholm

Director/Board Member

Chief Executive Officer

University of Kent College/University

Anthony Brown

Undergraduate Degree

CIRCIO HOLDING ASA Biotechnology

Øystein Soug

Jónas Einarsson

Gustav Gaudernack

Chief Executive Officer

Chairman

Founder

SHIELD THERAPEUTICS PLC Pharmaceuticals: Major

Christian Schweiger

Founder

Ulvenveien 90 ANS Miscellaneous

Henrik Schüssler

Director/Board Member

Huj Eiendom AS

Henrik Schüssler

Director/Board Member

ANS Ostre Aker Vei 24 B Miscellaneous

Henrik Schüssler

Director/Board Member

Østre Rosten Utvikling AS

Henrik Schüssler

Director/Board Member

EXACT THERAPEUTICS Biotechnology

Aitana Peire

Susanne Stuffers

Director/Board Member

Director/Board Member

Tachris AG

Christian Schweiger

President

Biotechnology

Jónas Einarsson

Aitana Peire

Øyvind Kongstun Arnesen

Chairman

Director/Board Member

Chairman

AOP Orphan International AG

Christian Schweiger

Director/Board Member

Statistik

International

Norwegen 24
Vereinigtes Königreich 11
Schweden 7
Vereinigte Staaten 6
Schweiz 4

Sektoral

Health Technology 23
Consumer Services 12
Commercial Services 5
Finance 5
Miscellaneous 3

Operativ

Director/Board Member 309
Corporate Officer/Principal 89
Chairman 82
Chief Executive Officer 58
Independent Dir/Board Member 35
  1. Börse
  2. Insiders
  3. Kari Grønås
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT